Patent: 5,840,299
✉ Email this page to a colleague
Summary for Patent: 5,840,299
Title: | Humanized antibodies against leukocyte adhesion molecule VLA-4 |
Abstract: | The invention provides humanized immunoglobulins that specifically bind to the VLA-4 ligand, and methods of treatment using the same. The methods are particularly useful for treatment of multiple sclerosis. |
Inventor(s): | Bendig; Mary M. (London, GB), Leger; Olivier J. (Hertfordshire, GB), Saldanha; Jose (Enfield Middlesex, GB), Jones; S. Tarran (Radlett, GB), Yednock; Ted A. (Fairfax, CA) |
Assignee: | Athena Neurosciences, Inc. (South San Francisco, CA) |
Application Number: | 08/561,521 |
Patent Claims: | see list of patent claims |
Details for Patent 5,840,299
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Genentech, Inc. | AVASTIN | bevacizumab | Injection | 125085 | 02/26/2004 | ⤷ Try a Trial | 2014-01-25 |
Biogen Inc. | TYSABRI | natalizumab | Injection | 125104 | 11/23/2004 | ⤷ Try a Trial | 2014-01-25 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
International Patent Family for US Patent 5,840,299
Country | Patent Number | Estimated Expiration |
---|---|---|
Austria | 333895 | ⤷ Try a Trial |
Australia | 1273697 | ⤷ Try a Trial |
Australia | 1696095 | ⤷ Try a Trial |
>Country | >Patent Number | >Estimated Expiration |